glp 1 drugs and vision loss GLP-1 are associated with a 35% higher risk of NAION, an eye condition that can cause sudden loss. About 6 to 10 extra cases per 10,000 users over 3 years How GLP-1 Drugs Could Cause

The effects of GLP1(736) on cells may also be indirect, mediated through insulin and glucagon released by and cells, respectively, which can alter somatostatin secretion

Its crucial to remember that while all these medications can help in weight management, their effectiveness is significantly amplified when combined with a healthy diet and regular exercise

10.1172/JCI105685 144 PhungO

GLP-1 is secreted by intestinal cells to regulate blood glucose levels by promoting insulin production

For instance, Wegovy is a GLP-1 RA specifically approved for weight loss while also being researched for other medical uses such as metabolic conditions